title: Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection.
abstract: The proportion of group D streptococcal infective endocarditis (IE) (predominantly due to Streptococcus gallolyticus) and the incidence of colorectal cancer are higher in France than in most European countries. We assumed that this could be explained by a high group D streptococci (GDS) fecal carriage rate. The aims of this study were to re-assess the GDS fecal carriage rate in France and its relationship with colorectal cancer. Consecutive adult subjects who were to undergo a complete colonoscopy were invited to participate. GDS were searched in subjects' stools before their colonoscopy using biomolecular techniques. Colonoscopic findings were sorted into four subgroups: normal colonoscopy, non-tumoral lesions, benign tumors, and premalignant/malignant tumors. GDS fecal carriages were calculated overall and in each subgroup and compared. The data from 259 subjects were analyzed. GDS were identified in the feces of 12 subjects, with the following distribution: S. lutetiensis (n = 9), S. pasteurianus (n = 2), and S. gallolyticus (n = 1). This accounted for an overall GDS fecal carriage rate of 4.6 %. The GDS fecal carriage rate was 6 % in case of normal colonoscopy, 1.3 % in case of non-tumoral lesions, 3.2 % in case of benign tumors, and 11 % in case of premalignant/malignant tumors. These four percentages were not statistically different. The GDS fecal carriage rate was lower than expected, which did not confirm our working hypothesis. Most strains belonged to S. bovis biotype II, while S. gallolyticus was found only once. These findings suggest that different GDS play different roles in the etiopathogenesis of IE and colorectal cancer.
authors.affiliation: Department of Infectious Diseases, University of Franche-Comté, UMR 6249, University Hospital, 25000 Besançon, France. cchirouze@chu-besancon.fr
authors.forename: C
authors.initials: C
authors.lastname: Chirouze
authors.forename: I
authors.initials: I
authors.lastname: Patry
authors.forename: X
authors.initials: X
authors.lastname: Duval
authors.forename: V
authors.initials: V
authors.lastname: Baty
authors.forename: P
authors.initials: P
authors.lastname: Tattevin
authors.forename: T
authors.initials: T
authors.lastname: Aparicio
authors.forename: M
authors.initials: M
authors.lastname: Pagenault
authors.forename: F
authors.initials: F
authors.lastname: Carbonnel
authors.forename: G
authors.initials: G
authors.lastname: Couetdic
authors.forename: B
authors.initials: B
authors.lastname: Hoen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002353:Carrier State; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000382:microbiology; D004697:Endocarditis, Bacterial / Q000453:epidemiology* / Q000382:microbiology; D005243:Feces / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D013290:Streptococcal Infections / Q000453:epidemiology / Q000382:microbiology; D016985:Streptococcus bovis / Q000302:isolation & purification*; D018502:Streptococcus equi / Q000302:isolation & purification*; D055815:Young Adult
chemical_list: D012336:RNA, Ribosomal, 16S
references.citation: Clin Microbiol Infect. 2007 Aug;13(8):770-6
references.pmid: 17501973
references.citation: Eur Heart J. 1995 Mar;16(3):394-401
references.pmid: 7789383
references.citation: Ann Intern Med. 1979 Oct;91(4):560-2
references.pmid: 484953
references.citation: Int J Microbiol. 2011;2011:792019
references.pmid: 22121365
references.citation: Carcinogenesis. 2000 Apr;21(4):753-6
references.pmid: 10753212
references.citation: Mol Cancer. 2010 Sep 17;9:249
references.pmid: 20846456
references.citation: Gastroenterology. 1991 Sep;101(3):721-5
references.pmid: 1823534
references.citation: Clin Infect Dis. 2011 Nov;53(9):870-8
references.pmid: 21960713
references.citation: Eur Heart J. 2009 Oct;30(19):2369-413
references.pmid: 19713420
references.citation: JAMA. 2002 Jul 3;288(1):75-81
references.pmid: 12090865
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4578-85
references.pmid: 20668239
references.citation: Am J Gastroenterol. 1985 Jan;80(1):42-6
references.pmid: 3966453
references.citation: J Clin Microbiol. 2003 Apr;41(4):1785-7
references.pmid: 12682188
references.citation: Int J Cancer. 2012 Nov 15;131(10):2294-9
references.pmid: 22377818
references.citation: Eur J Clin Microbiol Infect Dis. 2008 Apr;27(4):285-91
references.pmid: 18183440
references.citation: Clin Microbiol Infect. 2005 Oct;11(10):814-9
references.pmid: 16153255
references.citation: J Clin Gastroenterol. 1993 Jul;17(1):25-8
references.pmid: 8409294
references.citation: Arch Surg. 2004 Jul;139(7):760-5
references.pmid: 15249410
references.citation: J Infect Dis. 2011 Apr 15;203(8):1101-9
references.pmid: 21451000
references.citation: J Bacteriol. 1991 Jan;173(2):697-703
references.pmid: 1987160
references.citation: BMC Cancer. 2009 Nov 19;9:403
references.pmid: 19925668
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14691-6
references.pmid: 20679230
references.citation: Appl Environ Microbiol. 2004 Oct;70(10):6113-22
references.pmid: 15466557
references.citation: Ann Oncol. 2007 Mar;18(3):581-92
references.pmid: 17287242
references.citation: Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):12-6
references.pmid: 15660254
references.citation: N Engl J Med. 1977 Oct 13;297(15):800-2
references.pmid: 408687
references.citation: Clin Infect Dis. 1994 Aug;19(2):361-2
references.pmid: 7986925
references.citation: J Clin Pathol. 1998 Jun;51(6):473-4
references.pmid: 9771449
references.citation: Carcinogenesis. 2004 Aug;25(8):1477-84
references.pmid: 14742316
references.citation: Int J Syst Evol Microbiol. 2003 May;53(Pt 3):631-645
references.pmid: 12807180
references.citation: Clin Infect Dis. 2012 May;54(9):1230-9
references.pmid: 22492317
references.citation: Asian Pac J Cancer Prev. 2010;11(6):1765-8
references.pmid: 21338230
references.citation: PLoS One. 2011;6(7):e22109
references.pmid: 21829445
references.citation: Antimicrob Agents Chemother. 2005 Apr;49(4):1646-8
references.pmid: 15793162
references.citation: Clin Infect Dis. 2004 May 15;38(10):1394-400
references.pmid: 15156477
references.citation: BMC Cancer. 2011 Jun 30;11:282
references.pmid: 21718477